Drug Patents owned by Exela Pharma

1. Drug name - ELCYS

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10583155 EXELA PHARMA Stable, highly pure L-cysteine compositions for injection and methods of use Jan, 2039

(16 years from now)

US10905714 EXELA PHARMA Stable, highly pure L-cysteine compositions for injection and methods of use Jan, 2039

(16 years from now)

US10653719 EXELA PHARMA Stable, highly pure L-cysteine compositions for injection and methods of use Jan, 2039

(16 years from now)

US10478453 EXELA PHARMA Stable, highly pure L-cysteine compositions for injection and methods of use Jan, 2039

(16 years from now)

US10933089 EXELA PHARMA Stable, highly pure L-cysteine compositions for injection and methods of use Jan, 2039

(16 years from now)

US10905713 EXELA PHARMA Stable, highly pure L-cysteine compositions for injection and methods of use Jan, 2039

(16 years from now)

US10912795 EXELA PHARMA Stable, highly pure L-cysteine compositions for injection and methods of use Jan, 2039

(16 years from now)

US10918662 EXELA PHARMA Stable, highly pure L-cysteine compositions for injection and methods of use Jan, 2039

(16 years from now)

Drugs and Companies using CYSTEINE HYDROCHLORIDE ingredient

Treatment: Method of using l-cysteine in an admixture for treating patients needing parenteral nutrition

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
500MG/10ML (50MG/ML) SOLUTION;INTRAVENOUS Prescription

2. Drug name - GANZYK-RTU

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9486530 EXELA PHARMA Ganciclovir compositions and related methods Sep, 2034

(11 years from now)

Drugs and Companies using GANCICLOVIR ingredient

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
500MG/250ML (2MG/ML) SOLUTION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.